Logo image of PYCR

PAYCOR HCM INC (PYCR) Stock Fundamental Analysis

NASDAQ:PYCR - Nasdaq - US70435P1021 - Common Stock - Currency: USD

22.21  -0.01 (-0.05%)

After market: 22.21 0 (0%)

Fundamental Rating

3

PYCR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 82 industry peers in the Professional Services industry. The financial health of PYCR is average, but there are quite some concerns on its profitability. PYCR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

PYCR had positive earnings in the past year.
In the past year PYCR had a positive cash flow from operations.
In the past 5 years PYCR always reported negative net income.
PYCR had a positive operating cash flow in each of the past 5 years.
PYCR Yearly Net Income VS EBIT VS OCF VS FCFPYCR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

With a Return On Assets value of -0.76%, PYCR is not doing good in the industry: 68.35% of the companies in the same industry are doing better.
PYCR's Return On Equity of -1.64% is on the low side compared to the rest of the industry. PYCR is outperformed by 67.09% of its industry peers.
Industry RankSector Rank
ROA -0.76%
ROE -1.64%
ROIC N/A
ROA(3y)-3.25%
ROA(5y)-3.81%
ROE(3y)-7.07%
ROE(5y)-8.34%
ROIC(3y)N/A
ROIC(5y)N/A
PYCR Yearly ROA, ROE, ROICPYCR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -2 -4 -6 -8 -10

1.3 Margins

Looking at the Gross Margin, with a value of 65.97%, PYCR is in the better half of the industry, outperforming 77.22% of the companies in the same industry.
PYCR's Gross Margin has been stable in the last couple of years.
PYCR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.45%
GM growth 5Y1.09%
PYCR Yearly Profit, Operating, Gross MarginsPYCR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

4

2. Health

2.1 Basic Checks

PYCR does not have a ROIC to compare to the WACC, probably because it is not profitable.
PYCR has more shares outstanding than it did 1 year ago.
PYCR has more shares outstanding than it did 5 years ago.
PYCR has a worse debt/assets ratio than last year.
PYCR Yearly Shares OutstandingPYCR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
PYCR Yearly Total Debt VS Total AssetsPYCR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

PYCR has an Altman-Z score of 1.62. This is a bad value and indicates that PYCR is not financially healthy and even has some risk of bankruptcy.
PYCR has a worse Altman-Z score (1.62) than 69.62% of its industry peers.
There is no outstanding debt for PYCR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.62
ROIC/WACCN/A
WACC9.14%
PYCR Yearly LT Debt VS Equity VS FCFPYCR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.12 indicates that PYCR should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.12, PYCR is doing worse than 62.03% of the companies in the same industry.
PYCR has a Quick Ratio of 1.12. This is a normal value and indicates that PYCR is financially healthy and should not expect problems in meeting its short term obligations.
PYCR has a Quick ratio of 1.12. This is in the lower half of the industry: PYCR underperforms 62.03% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 1.12
PYCR Yearly Current Assets VS Current LiabilitesPYCR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

6

3. Growth

3.1 Past

PYCR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.73%, which is quite impressive.
PYCR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.73%.
PYCR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.57% yearly.
EPS 1Y (TTM)27.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.09%
Revenue 1Y (TTM)15.73%
Revenue growth 3Y22.9%
Revenue growth 5Y17.57%
Sales Q2Q%13.1%

3.2 Future

Based on estimates for the next years, PYCR will show a very strong growth in Earnings Per Share. The EPS will grow by 21.73% on average per year.
The Revenue is expected to grow by 12.08% on average over the next years. This is quite good.
EPS Next Y19.69%
EPS Next 2Y16.19%
EPS Next 3Y15.87%
EPS Next 5Y21.73%
Revenue Next Year12.2%
Revenue Next 2Y11.75%
Revenue Next 3Y12.24%
Revenue Next 5Y12.08%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PYCR Yearly Revenue VS EstimatesPYCR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
PYCR Yearly EPS VS EstimatesPYCR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0.5 1 1.5 2

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 39.66, which means the current valuation is very expensive for PYCR.
70.89% of the companies in the same industry are cheaper than PYCR, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 29.63. PYCR is valued slightly more expensive when compared to this.
The Price/Forward Earnings ratio is 32.90, which means the current valuation is very expensive for PYCR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PYCR indicates a slightly more expensive valuation: PYCR is more expensive than 67.09% of the companies listed in the same industry.
PYCR's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.68.
Industry RankSector Rank
PE 39.66
Fwd PE 32.9
PYCR Price Earnings VS Forward Price EarningsPYCR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PYCR indicates a slightly more expensive valuation: PYCR is more expensive than 73.42% of the companies listed in the same industry.
67.09% of the companies in the same industry are cheaper than PYCR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 70.44
EV/EBITDA 33.73
PYCR Per share dataPYCR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PYCR does not grow enough to justify the current Price/Earnings ratio.
PYCR's earnings are expected to grow with 15.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.01
PEG (5Y)N/A
EPS Next 2Y16.19%
EPS Next 3Y15.87%

0

5. Dividend

5.1 Amount

PYCR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PAYCOR HCM INC

NASDAQ:PYCR (2/21/2025, 8:00:01 PM)

After market: 22.21 0 (0%)

22.21

-0.01 (-0.05%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)02-05 2025-02-05/amc
Earnings (Next)N/A N/A
Inst Owners43.22%
Inst Owner Change2.2%
Ins Owners1.22%
Ins Owner Change40.35%
Market Cap4.04B
Analysts68.18
Price Target23.07 (3.87%)
Short Float %3.46%
Short Ratio1.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.63%
Min EPS beat(2)20.66%
Max EPS beat(2)28.59%
EPS beat(4)4
Avg EPS beat(4)17.12%
Min EPS beat(4)3.43%
Max EPS beat(4)28.59%
EPS beat(8)8
Avg EPS beat(8)25.77%
EPS beat(12)12
Avg EPS beat(12)33.54%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.55%
Min Revenue beat(2)-0.14%
Max Revenue beat(2)1.24%
Revenue beat(4)2
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)1.24%
Revenue beat(8)6
Avg Revenue beat(8)0.4%
Revenue beat(12)10
Avg Revenue beat(12)1.28%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.28%
PT rev (3m)23.92%
EPS NQ rev (1m)4.34%
EPS NQ rev (3m)-1.04%
EPS NY rev (1m)4.48%
EPS NY rev (3m)5.18%
Revenue NQ rev (1m)0.5%
Revenue NQ rev (3m)-2.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.11%
Valuation
Industry RankSector Rank
PE 39.66
Fwd PE 32.9
P/S 5.77
P/FCF 70.44
P/OCF 34.01
P/B 3.08
P/tB 12.1
EV/EBITDA 33.73
EPS(TTM)0.56
EY2.52%
EPS(NY)0.68
Fwd EY3.04%
FCF(TTM)0.32
FCFY1.42%
OCF(TTM)0.65
OCFY2.94%
SpS3.85
BVpS7.2
TBVpS1.84
PEG (NY)2.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.76%
ROE -1.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.97%
FCFM 8.19%
ROA(3y)-3.25%
ROA(5y)-3.81%
ROE(3y)-7.07%
ROE(5y)-8.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.45%
GM growth 5Y1.09%
F-Score6
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 47.16%
Cap/Sales 8.77%
Interest Coverage N/A
Cash Conversion 102.02%
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 1.12
Altman-Z 1.62
F-Score6
WACC9.14%
ROIC/WACCN/A
Cap/Depr(3y)42.74%
Cap/Depr(5y)34.82%
Cap/Sales(3y)10.54%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.09%
EPS Next Y19.69%
EPS Next 2Y16.19%
EPS Next 3Y15.87%
EPS Next 5Y21.73%
Revenue 1Y (TTM)15.73%
Revenue growth 3Y22.9%
Revenue growth 5Y17.57%
Sales Q2Q%13.1%
Revenue Next Year12.2%
Revenue Next 2Y11.75%
Revenue Next 3Y12.24%
Revenue Next 5Y12.08%
EBIT growth 1Y83.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year116.66%
EBIT Next 3Y43.84%
EBIT Next 5YN/A
FCF growth 1Y324.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y383.14%
OCF growth 3Y102.92%
OCF growth 5YN/A